AAAAAA

   
Results: 1-9 |
Results: 9
HYPERTENSIVE CRISES FOLLOWING PLATELET TRANSFUSIONS IN A PATIENT ON ERYTHROPOIETIN THERAPY
Authors: CARAVACA F FERNANDEZ A BARQUILLA JF ARROBAS M
Citation: F. Caravaca et al., HYPERTENSIVE CRISES FOLLOWING PLATELET TRANSFUSIONS IN A PATIENT ON ERYTHROPOIETIN THERAPY, Nephrology, dialysis, transplantation, 12(4), 1997, pp. 815-817
EFFECT OF COMPOSTED SEWAGE-SLUDGE AMENDMENT ON SOIL-NITROGEN AND PHOSPHORUS AVAILABILITY
Authors: COUTINHO J ARROBAS M RODRIGUES O
Citation: J. Coutinho et al., EFFECT OF COMPOSTED SEWAGE-SLUDGE AMENDMENT ON SOIL-NITROGEN AND PHOSPHORUS AVAILABILITY, Communications in soil science and plant analysis, 28(19-20), 1997, pp. 1845-1857
RELATIONSHIP BETWEEN UREA CLEARANCE AND P ROTEIN CATABOLIC RATE - IMPORTANCE OF THE RESIDUAL RENAL-FUNCTION
Authors: CARAVACA F CID MC GALAN J GARCIA MC CUBERO JJ ARROBAS M DOMINGUEZ C PIZARRO JL
Citation: F. Caravaca et al., RELATIONSHIP BETWEEN UREA CLEARANCE AND P ROTEIN CATABOLIC RATE - IMPORTANCE OF THE RESIDUAL RENAL-FUNCTION, Nefrologia, 16(3), 1996, pp. 228-235
HEMODYNAMIC-CHANGES INDUCED BY THE CORRECTION OF ANEMIA BY ERYTHROPOIETIN - ROLE OF ANTIPLATELET THERAPY
Authors: CARAVACA F LOPEZMINGUEZ JR ARROBAS M CUBERO J PIZARRO JL CID MC SANCHEZCASADO E MIRANDA MP
Citation: F. Caravaca et al., HEMODYNAMIC-CHANGES INDUCED BY THE CORRECTION OF ANEMIA BY ERYTHROPOIETIN - ROLE OF ANTIPLATELET THERAPY, Nephrology, dialysis, transplantation, 10(9), 1995, pp. 1720-1724
PREDICTIVE FACTORS OF DELAYED RENAL-ALLOGRAFT FUNCTION (DAF) - INFLUENCES OF SECONDARY HYPERPARATHYROIDISM (HPT)
Authors: CID M CUBERO JJ CARAVACA F ESPARRAGO JF GARCIA MC RONCERO F ARROBAS M PIZARRO JL CASADO ES
Citation: M. Cid et al., PREDICTIVE FACTORS OF DELAYED RENAL-ALLOGRAFT FUNCTION (DAF) - INFLUENCES OF SECONDARY HYPERPARATHYROIDISM (HPT), Kidney international, 48(1), 1995, pp. 294-294
ANTIPLATELET THERAPY AND DEVELOPMENT OF HYPERTENSION INDUCED BY RECOMBINANT-HUMAN-ERYTHROPOIETIN IN UREMIC PATIENTS
Authors: CARAVACA F PIZARRO JL ARROBAS M CUBERO JJ GARCIA MC PEREZMIRANDA M
Citation: F. Caravaca et al., ANTIPLATELET THERAPY AND DEVELOPMENT OF HYPERTENSION INDUCED BY RECOMBINANT-HUMAN-ERYTHROPOIETIN IN UREMIC PATIENTS, Kidney international, 45(3), 1994, pp. 845-851
FIBRILLAR GLOMERULONEPHRITIS - DESCRIPTIO N OF A NEW CASE
Authors: GARCIA MC ARROBAS M CARAVACA F FERNANDEZALONSO J
Citation: Mc. Garcia et al., FIBRILLAR GLOMERULONEPHRITIS - DESCRIPTIO N OF A NEW CASE, Nefrologia, 13(4), 1993, pp. 347-349
CHANGES IN PLATELET COUNT - A PRIMARY OR SECONDARY EFFECT OF RHU-EPO THERAPY
Authors: CARAVACA F GARCIA MC APARICIO A VAGACE JM ARROBAS M CUBERO J PIZARRO JL ESPARRAGO J SANCHEZCASADO E
Citation: F. Caravaca et al., CHANGES IN PLATELET COUNT - A PRIMARY OR SECONDARY EFFECT OF RHU-EPO THERAPY, Nefrologia, 13(3), 1993, pp. 249-251
CALCIPHYLAXIS AND CALCIUM-CARBONATE
Authors: DIAZ MCG ROBLES NR ARROBAS M CASADO ES
Citation: Mcg. Diaz et al., CALCIPHYLAXIS AND CALCIUM-CARBONATE, Nefrologia, 13(1), 1993, pp. 86-87
Risultati: 1-9 |